This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
Abstract: In the world more then 10% people are suffering from lung cancer, due to this there is a need for frameworks that can detects the lung cancer at preliminary stage. However, most of the ...
Background: During the diagnosis and treatment of non–small cell lung cancer (NSCLC), detecting the risk of its recurrence in an early phase is still challenging. Recent studies have investigated the ...
Abstract: Lung cancer creates a tremendous source of cancer deaths around the world, calling attention to the requirements of accurate, automated interpretation of ...
The EGFR signaling pathway is a critical driver in the occurrence and development of non-small cell lung cancer (NSCLC). However, the inevitable development of acquired resistance to EGFR tyrosine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results